699 results on '"Tison, François"'
Search Results
2. Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions
3. Avant-propos
4. Care of Late‐Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries
5. Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database
6. Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment
7. Expanding the clinical spectrum of STIP1 homology and U-box containing protein 1-associated ataxia
8. Cognitive and functional changes in prediagnostic phase of Parkinson disease: A population-based study
9. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations
10. Differential annualized rates of hippocampal subfields atrophy in aging and future Alzheimer's clinical syndrome
11. The late stage of Parkinson's –results of a large multinational study on motor and non-motor complications
12. L’Institut de Médecine Intégrative et Complémentaire (IMIC) du CHU de Bordeaux
13. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.
14. PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability
15. Evolution of brain atrophy subtypes during aging predicts long-term cognitive decline and future Alzheimer's clinical syndrome
16. Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study
17. Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease
18. Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment
19. Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature
20. Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort
21. Acute toxic limbic encephalopathy following glyphosate intoxication
22. No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease in nine ADHD candidate SNPs
23. Prediction of visual attention with deep CNN on artificially degraded videos for studies of attention of patients with Dementia
24. Multiple System Atrophy - State of the Art
25. Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
26. The Differential Diagnosis of Neuroacanthocytosis: An Overview
27. Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (“n-of-1”) exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients
28. The natural history of multiple system atrophy: a prospective European cohort study
29. Traitement médicamenteux de la maladie de Parkinson
30. Trends in Prevalence of Dementia in French Farmers from Two Epidemiological Cohorts
31. Risk of dementia in an elderly population of Parkinson's disease patients: A 15-year population-based study
32. A French family with Charcot–Marie–Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations
33. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial
34. Restless legs syndrome in multiple system atrophy
35. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls
36. Rheumatologic and neurological events in an elderly patient with tricho-rhino-phalangeal syndrome type I
37. Liste des auteurs
38. Épidémiologie
39. Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy
40. IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP
41. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinsonʼs disease with a sexual dimorphism
42. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinsonʼs disease
43. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson’s disease
44. International Validation of a Behavioral Scale in Parkinsonʼs Disease Without Dementia
45. Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model
46. Breathing Variability and Brainstem Serotonergic Loss in A Genetic Model of Multiple System Atrophy
47. Intra-axonal protein aggregation in the peripheral nervous system
48. MOVEMENT DISORDERS IN 2013: Diagnosing and treating PD—the earlier the better?
49. Isolated generalized dystonia in biallelic missense mutations of the ATM gene
50. Genetic and phenotypic basis of autosomal dominant Parkinson's disease in a large multi-center cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.